Kancera:Swedish, 20 employee, phase 1 b, Immuno Oncology April 2016: Former senior AZ manager Charlotte Edenius gets a BoD position st Kancera August 2016: Former senior AZ manager Niclas Brynne gets title Chief Development Officer at Kancera December 2016: Former AZ global director gets title Chief Medical Officer at Kancera June 2018: AZ Medical Science Director gets BoD position in Kancera Is this a coincidence? I think not. In March 2018 AstraZeneca and Kancera presented a study together within cancer metabolism. The main focus of Kancera since 2016 is to optimize an old AZ candidate (AZD8797, now KAND567).
